Template:Butalbital/aspirin/caffeine/codeine: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; ! style="padding: 0 5px; font-size: 100%; background:#F8F8...") |
No edit summary |
||
Line 1: | Line 1: | ||
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | {| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | ||
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Butalbital/aspirin/caffeine/codeine|{{fontcolor|#6C7B8B| | ! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Butalbital/aspirin/caffeine/codeine|{{fontcolor|#6C7B8B|Butalbital/aspirin/caffeine/codeine}}]]''''' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ASCOMP WITH CODEINE (butalbital, aspirin, cafeine, and codeine phosphate) capsule<sup>®</sup> FDA Package Insert | ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ASCOMP WITH CODEINE (butalbital, aspirin, cafeine, and codeine phosphate) capsule<sup>®</sup> FDA Package Insert |
Revision as of 23:38, 11 February 2014
Butalbital/aspirin/caffeine/codeine |
---|
ASCOMP WITH CODEINE (butalbital, aspirin, cafeine, and codeine phosphate) capsule® FDA Package Insert |
Indications and Usage |
Dosage and Administration |
Dosage Forms and Strengths |
Contraindications |
Warnings and Precautions |
Adverse Reactions |
Drug Interactions |
Use in Specific Populations |
Overdosage |
Description |
Clinical Pharmacology |
Nonclinical Toxicology |
Clinical Studies |
How Supplied/Storage and Handling |
Patient Counseling Information |
Labels and Packages |
Clinical Trials on ASCOMP WITH CODEINE (butalbital, aspirin, cafeine, and codeine phosphate) capsule |
ClinicalTrials.gov |